Full Text
PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS

Abstract

Authors

BS Woods NS Hawkins

Back to Volume 12, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×